Motley Fool  Jul 15  Comment 
The favorite and most important equipment at Moema supports fermentation. What Solazyme investors need to know.
SeekingAlpha  Jul 14  Comment 
By Kevin Quon: When it comes to oil & gas exploration, it is often difficult to find green companies that are advancing a sustainable business in this industry. Yet for renewable oils and bioproducts producer, Solazyme (NASDAQ:SZYM), the mission...
Motley Fool  Jul 6  Comment 
Ecover has decided to investigate its use of Solazyme's renewable algal oils before deciding the future of its supply, which brings one important risk to light for investors.
Motley Fool  Jun 25  Comment 
Let's see what the numbers say about Solazyme.
SeekingAlpha  Jun 23  Comment 
By Kevin Quon: Renewable oils and bioproducts producer, Solazyme (SZYM), is a small company largely known for its production of algae-based biofuels for the US Navy and for the development of a high-end cosmetic line called Algenist. The company...
StreetInsider.com  Jun 20  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Solazyme+%28SZYM%29+Enters+Exchange+Agreements+with+Certain+6%25+Conv.+Note+Holders/9600253.html for the full story.
Motley Fool  Jun 17  Comment 
Let's set the facts straight before the misinformation takes holds.
SeekingAlpha  Jun 16  Comment 
By Kevin Quon: Renewable oils and bioproducts producer Solazyme (SZYM) officially initiated production at its largest manufacturing facility with partner Bunge (BG) on May 29. In my previous article found here, I described how this new facility...
Motley Fool  Jun 14  Comment 
Synthetic biology has now come under fire from the same activist groups targeting Monsanto. The first victim? Renewable oils manufacturer Solazyme.
SeekingAlpha  Jun 1  Comment 
By Kevin Quon: Renewable oils and bioproducts producer, Solazyme (SZYM), is in the business of using biotechnology to solve some of society's largest problems with some of the world's smallest organisms. The heterotrophic algae producer uses a...


Solazyme (NASDAQ:SZYM) transforms plant-based sugars into petroleum-based products for the chemical industry, fuels, nutrition and skin and personal care products and is scaling up manufacturing capacity in order to better serve these markets. In order to alleviate the manufacturing capacity constraint, Solazyme uses a mixed operational strategy approach including contract manufacturing, and joint ventures. The company's primary revenues are derived from producing oil via an indirect photosynthesis technology. As opposed to common open-pond and photo bio reactor approach, Solazyme uses feeds sugars to proprietary oil-producing micro-algae in a dark fermentation tank to accelerate normal production time. [1]

The rapidly growing demand and depleting supply for oils in today's society has created a need to look to alternatives sources of oil. As a whole, the alternative fuel industry has several advantages including the ability to scale production in order to minimize price variability. The controlled bio reactor production technology also enables company's like Solazyme to produce tailored, high-end fuels for specialized markets.


The company's initial public offering of stock on the NASDAQ occurred on May 27, 2011. The company offered 11M shares each for $18, which was at the high end of the $15-$17 price range. The offering raised a total of $198M. The lead managers of the IPO were Morgan Stanley (MS) and Goldman Sachs Group (GS).[3]

During the full year 2010, the company reported a total revenue of $38M and incurred a net loss of $16M. This represents a 400% increase in total revenue and a 19% increase in net loss with respect to 2009. [4]

  1. SYZM S-1/A 2011 PROSPECTUS SUMMARY "Prospectus Summary" pg 1-3
  2. SYZM S-1/A 2011 PROSPECTUS SUMMARY "Overview" pg 1-6
  3. Renaissance Capital - IPO Home "Solazyme prices upsized IPO at $18, above the range" 27 May 2011
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki